Closing the "Black Hole" of Global Regulatory Labeling Submission for Biopharma
That’s the topic being discussed in this latest report from IDC, and it represents the scale of the challenge faced by global regulatory affairs professionals across the globe. In this highly regulated marketplace, pharmaceutical and biotech firms face a challenge in managing regulatory labeling submissions that meet multiple country and regional requirements in many different languages. This process has historically required substantial manual intervention and review by highly-paid professionals, adding unnecessary costs and delays in medicinal product launches.
Read this technology spotlight to understand why pharmaceutical and biotech firms are adopting cloud-based intelligent multilingual submission management systems to ensure compliance of their product information in multiple languages and geographies while reducing costs, errors and time-to-market.